The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction

Current Microbiology
Limei AiLiping Bai

Abstract

The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas system has emerged as the dominating tool for genome engineering, while also changes the speed and efficiency of metabolic engineering in conventional and non-conventional yeasts. Among these CRISPR-Cas systems, CRISPR-Cas9 technology has usually been applied for removing unfavorable target genes. Here, we used CRISPR-Cas9 technology to delete the gal80 gene in uracil-deficient strain and had successfully remolded the engineered Saccharomyces cerevisiae that can produce artemisinic acid without galactose induction. An L9(34) orthogonal test was adopted to investigate the effects of different factors on artemisinic acid production. Fermentation medium III with sucrose as carbon sources, 1% inoculum level, and 84-h culture time were identified as the optimal fermentation conditions. Under this condition, the maximum artemisinic acid production by engineered S. cerevisiae 1211-2 was 740 mg/L in shake-flask cultivation level. This study provided an effective approach to reform metabolic pathway of artemisinic acid-producing strain. The engineered S. cerevisiae 1211-2 may be applied to artemisinic acid production by industrial fermentation in the future.

References

Jun 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D LohrJ Zlatanova
Jun 5, 2003·Nature Biotechnology·Vincent J J MartinJay D Keasling
Apr 3, 2007·Nature Protocols·R Daniel Gietz, Robert H Schiestl
Jan 5, 2008·Biotechnology and Bioengineering·Eric M ParadiseJay D Keasling
May 21, 2009·Applied Microbiology and Biotechnology·Shohei KanekoAkihiko Kondo
Sep 14, 2010·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Venkat Reddy PannalaK V Venkatesh
Jan 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Patrick J WestfallChris J Paddon
Jan 18, 2012·Angewandte Chemie·François Lévesque, Peter H Seeberger
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Mar 6, 2013·Nucleic Acids Research·James E DiCarloGeorge M Church
Apr 2, 2014·Nature Reviews. Microbiology·Chris J Paddon, Jay D Keasling
May 21, 2015·Nature Chemistry·Zacharias AmaraMichael W George
Jul 8, 2015·Microbial Cell Factories·Carlotta RondaAlex Toftgaard Nielsen
Jun 22, 2016·Journal of Microbiological Methods·Wesley Cardoso GenerosoEckhard Boles
Dec 3, 2016·Nucleic Acids Research·Amanda Reider ApelAindrila Mukhopadhyay
Nov 25, 2017·Methods in Molecular Biology·Tadas JakočiūnasJay D Keasling
Dec 24, 2017·Current Opinion in Biotechnology·Pamela B Besada-LombanaNancy A Da Silva
Jan 19, 2018·Yeast·Marcin G FraczekDaniela Delneri
Feb 6, 2018·Trends in Microbiology·Baharul I Choudhury, Malcolm Whiteway
Feb 8, 2018·Current Opinion in Biotechnology·Ioannis MougiakosRichard van Kranenburg
Apr 8, 2018·Current Genetics·Inga SoreanuAmir Aharoni

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR

Software Mentioned

Shimadzu LCsolution Revision

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.